UPDATED May 21, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VWS | kr.191.50 | -2.8% | -4.0% | kr.195.5b | kr.222.81 | PS1.7x | E39.3% | n/a | Capital Goods | ||
NOVO B | kr.920.60 | 0.4% | 64.2% | kr.4.1t | kr.909.23 | PE45.7x | E13.3% | 1.0% | Pharmaceuticals & Biotech |